Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors

Abstract

Response to preoperative chemotherapy is significantly higher for patients with endocrine nonresponsive tumors. New chemotherapy regimens or combinations should be explored in this cohort of patients with poor outcome. For patients with endocrine responsive disease, the role of preoperative endocrine therapies should be studied.